Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$632,099
+$197,048 QoQ
Shares Held
527
+11.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#3,549
of 4,604 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DAVIDSON TRUST CO holds $18,040,710 across 10 Drug Manufacturers - General names. LLY ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
33,886 | $8,527,072 | |
| 2 | JNJ |
Johnson & Johnson
|
18,611 | $4,726,634 | |
| 3 | PFE |
Pfizer Inc
|
43,036 | $1,036,306 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,832 | $877,912 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
12,206 | $703,309 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
527 | $632,099 | |
| 7 | NVS |
Novartis AG
|
3,685 | $577,512 | |
| 8 | AMGN |
Amgen Inc
|
1,361 | $492,845 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $632,099 | 527 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $435,051 | 473 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $585,700 | 545 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $491,372 | 644 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $502,017 | 644 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $706,153 | 855 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $413,020 | 535 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $476,635 | 538 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||